# Jasper Therapeutics, Inc.: Form 8-K, filed Aug 3, 2026

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 16:47 ET
- Period: 2026-07-31
- Accession: 0001213900-26-084687
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/ea0300286-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/ea0300286-8k_jasper.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-084687. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.